Partnerships and Community
Gilead is dedicated to developing innovative medicines for life-threatening illnesses – and we recognize that it takes more than medicine to address challenges people and communities face.
That’s why we work with organizations around the world to launch programs that help improve access to care by eliminating barriers and advancing education.

Fighting HIV in the Southern U.S. – COMPASS Initiative®
The Gilead COMPASS (COMmitment to Partnership in Addressing HIV in Southern States) Initiative is our $100+ million, 10-year commitment to help address HIV in the U.S. South.
Meeting the Needs of People Living and Aging with HIV – HIV Age Positively®
The Gilead HIV Age Positively program seeks to improve care, provide education, and inform policy for the growing number of individuals who are living and aging with HIV.


Toward Health Equity for Black People Impacted by Triple-Negative Breast Cancer
This grant funding supports organizations serving Black communities impacted by triple-negative breast cancer (TNBC). Understanding the impact of economic disparities and social determinants on health outcomes, these grants support organizations grounded in advancing education and awareness with the goal of improving health equity and access to breast cancer care.
Toward Health Equity Oncology Grant™ (THE Oncology Grant)
Toward Health Equity Oncology Grant™ (THE Oncology Grant) is an annual initiative to catalyze innovative approaches to improve health equity across the cancer care continuum. We award grants through this program annually on Feb. 4, World Cancer Day. THE Oncology Grant seeks to build on existing data, fund programs with a health equity approach and meaningful involvement of the community, illuminate replicable models, and identify sustainable outcomes.


Addressing HIV in Eastern Europe & Central Asia – RADIAN®
RADIAN is a ground-breaking partnership between Gilead Sciences and the Elton John AIDS Foundation to address new HIV infections and deaths from HIV-related illnesses in Eastern Europe & Central Asia to help improve the quality of prevention and care for people at risk of or living with HIV.